GABA-A receptor (via active metabolite phenobarbital)

Class

small molecule; the Mysoline (primidone) label states plainly: 'The mechanism(s) of primidone's antiepileptic action is not known.' Primidone itself has intrinsic anticonvulsant activity, but is also metabolized to two active metabolites, phenobarbital and phenylethylmalonamide (PEMA); the label notes 'PEMA potentiates the anticonvulsant activity of phenobarbital in experimental animals.'

Pathway

Primidone's own molecular target is not established per its label. A substantial part of its antiseizure effect is attributed to its metabolite phenobarbital, a barbiturate whose own FDA label (see Sezaby, phenobarbital sodium, cited separately in this batch) describes GABA-A receptor potentiation as its proposed mechanism.

GABA-A receptors are channels on nerve cells that open in response to the neurotransmitter GABA, allowing chloride ions to flow in and making the cell less likely to fire. This inhibitory braking system is central to preventing the excessive, synchronized electrical activity that characterizes seizures, which is why drugs that enhance GABA-A receptor activity are a long-standing strategy in epilepsy treatment.

Primidone is one such medicine, though its own molecular action is not firmly established. It has some anticonvulsant activity on its own, but much of its effect is thought to come after the liver converts it into two active byproducts: phenobarbital and phenylethylmalonamide (PEMA). Phenobarbital, a barbiturate, is believed to bind a site on the GABA-A receptor and prolong the opening of its chloride channel, deepening inhibitory signaling. PEMA appears to strengthen phenobarbital's effect rather than act independently. Together, this gives primidone a layered pharmacology: a parent compound with some direct activity plus two metabolites that reinforce inhibitory neurotransmission. This mechanism is broadly relevant across generalized and certain partial seizure types, and more generally illustrates how boosting inhibitory tone in the brain is used to raise the threshold for seizure activity.